Tregs also act as breaks on the immune system through immune checkpoint expression (CTLA-4 and PD-1), along with immunosuppressive cytokine (IL-10 and TGF-β) and metabolite (adenosine) secretion that affect a wide range of anti-tumor immune responses [148]. This evidence concerns the gene TGFB1 and neoplasm.